Questions over dabigatran education for GPs

However, dabigatran sponsor Boehringer Ingelheim (BI) says the company has undertaken a wide-ranging education program to ensure appropriate patients and dosages are selected.

Last year the PBAC recommended dabigatran (Pradaxa) for PBS listing for an AF indication, but a decision has been delayed pending a review of all new anticoagulants.